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Background. Frailty contributes to increased morbidity and mortality in patients referred for and undergoing lung transplantation
(LTX). &e study aim was to determine if frailty is reversible after LTX in those classified as frail at LTX evaluation. Methods.
Consecutive LTX recipients were included. All patients underwent modified physical frailty assessment during LTX evaluation.
For patients assessed as frail, frailty was reassessed on completion of the post-LTX rehabilitation program. Frailty was defined by
the presence of ≥ 3 domains of the modified Fried Frailty Phenotype (mFFP). Results. We performed 166 lung transplants (frail
patients, n� 27, 16%). Eighteen of the 27 frail patients have undergone frailty reassessment. Eight frail patients died, and one
interstate recipient did not return for reassessment. In the 18 (66%) patients reassessed, there was an overall reduction in their
frailty score post-LTX ((3.4± 0.6 to 1.0± 0.7), p< 0.001) with 17/18 (94%) no longer classified as frail. Improvements were seen in
the following frailty domains: exhaustion, mobility, appetite, and activity. Handgrip strength did not improve posttransplant.
Conclusions. Physical frailty was largely reversible following LTX, underscoring the importance of considering frailty a dynamic,
not a fixed, entity. Further work is needed to identify those patients whose frailty is modifiable and establish specific interventions
to improve frailty.
1. Background
Lung transplantation is a complex treatment and is asso-
ciated with a significant risk of adverse health outcomes
including infection, rejection, and death [1]. &e Interna-
tional Society of Heart and Lung Transplantation recognizes
the importance of appropriate candidate selection as a de-
terminant of lung transplant outcomes [2]. It is essential that
physiological contributors, including frailty, be considered
in the risk stratification of patients undergoing transplant
evaluation [3].
Frailty is a clinical syndrome characterized by decreased
reserve across multiple physiologic systems. Frailty syn-
drome is prevalent in community-dwelling elders and across
various chronic disease populations [4–6]. Frailty is pre-
dictive of short- and long-term morbidity and mortality in
numerous medical and surgical populations [7,8]. Frailty
assessment provides an effective method of risk stratification
in several patient populations, including those with ad-
vanced lung disease referred for transplantation [6, 7].
Frailty has been highlighted as an important consideration
in the assessment of lung transplant candidates across all
ages [3]. Our previous reports in patients referred for heart
or lung transplantation demonstrate that frailty is associated
with increased mortality on the waitlist and following
transplantation [4, 7, 9].
Pretransplant frailty assessment improves risk stratifi-
cation and helps refine candidate selection [6]. However,
currently, there is no international standard frailty measure.
A number of frailty measures exist and are used for pop-
ulation screening or clinical assessment [10]. &e two most
common frailty measures are Fried’s Phenotype and
Rockwood’s frailty index [5, 11]. Questions remain about the
optimal frailty measure in lung transplantation and which
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frailty domains are most amenable to intervention pre- and
post-lung transplantation. Physical frailty most often assessed
using Fried’s Frailty Phenotype is prevalent in LTX candidates
and incorporates components, such as exhaustion and slow
gait speed, that are likely to improve with LTX [3]. &e frailty
index is associated with lower posttransplant survival [12].
However, the frailty index is less likely to be disease-specific
and improve following LTX. In fact, the frailty index has the
potential to worsen with the addition of posttransplant
comorbidities, such as diabetes [3]. As frailtymeasures in lung
transplantation develop, it is important to ensure that the
frailty domains being measured are associated with the bi-
ological processes underlying advanced lung disease.
It has been reported that the implementation of ap-
propriate interventions may improve frailty and mitigate
further decline [13]. Prehabilitation includes exercise, nu-
tritional, and psychological components and is intended to
enhance functional capacity in preparation for future
physiologic stressors, such as surgery [14–16]. Pilot studies
have demonstrated that prehabilitation programs are ca-
pable of improving frailty in transplant candidates and may
potentially improve posttransplant outcomes [15, 16]. A
recent consensus statement on frailty in transplantation
recognized exercise and nutritional interventions as areas for
future study in the management of frailty in lung trans-
plantation [3]. Despite the high risk of adverse outcomes
among frail patients, there may be the potential for frailty to
improve prior to and following LTX [17].
Given the prevalence of frailty among those with advanced
lung disease referred for transplantation, our study aimed at
determining to what degree frailty is reversible following LTX
in those classified as frail at the time of LTX evaluation and
which specific domains of physical frailty are reversible.
2. Materials and Methods
2.1. Study Population. Between March 2013 and October
2017, 166 consecutive LTX recipients at our center were
included in the study. All patients underwent frailty, cog-
nition, and depression assessment as part of the routine
evaluation for LTX. All patients undergoing evaluation for
LTX are required to enroll in their local pulmonary reha-
bilitation program and continue pulmonary rehabilitation
while awaiting LTX. Pulmonary rehabilitation was based on
the Australian and New Zealand Pulmonary Rehabilitation
Guidelines [18]. Patients underwent an initial assessment
followed by individualized exercise training focused on
increasing physical function and education to help patients
manage their condition.
Following LTX, all recipients were enrolled in a 12-week
outpatient rehabilitation program at our center once they
have been discharged following LTX. Participants under-
went an initial assessment (six-minute walk distance and
health-related quality of life assessment) with programs
tailored to the individual consisting of sessions of upper and
lower extremity exercise, education, and psychosocial sup-
port. Based on our experience in heart transplant recipients,
we anticipated that frail patients would face a higher
mortality after transplant, and in those that survived, frailty
would largely be reversed. As such, during the study period,
18 patients assessed as frail pretransplant underwent reas-
sessment of frailty, cognition, and depression on completion
of the rehabilitation program following LTX.
St Vincent’s Hospital Human Research Ethics Com-
mittee approved the study (LNR/13/SVH/21). Informed
consent was obtained from all patients for their data to be
entered into the study database for analysis.
2.2. Frailty Assessment. Physical frailty was assessed using a
modified version of Fried’s Frailty Phenotype to categorize
patients as frail or nonfrail. Details of the modified assessment
tool have previously been published [19] and are outlined in
Table 1. Patients were assessed as frail if ≥ 3 domains of the
modified Fried Frailty Phenotype (mFFP) were present.
2.3. Cognition and Depression Assessment. &e Montreal
Cognitive Assessment (MOCA) questionnaire was used to
assess cognitive function [20], with a score less than 26/30
classified as cognitive impairment.
&e Depression in the Medically Ill (DMI-10) [21]
questionnaire was used to assess depression. A score of ≥ 9/
30 was classified as a likely case of clinical depression.
2.4. Hand Grip Strength. Hand grip strength (HGS) was
assessed using the Jamar Hand Dynamometer. Grip strength
was considered weak if the average of 3 consecutive attempts
on the left and right hand was less than 2 standard deviations
below the sex- and age-adjusted normal values. &e higher
average of the right-hand and left-hand averages was
recorded for baseline and follow-up HGS.
2.5. Assessment of Disease Severity. Markers of lung disease
severity were obtained as part of the routine pre-
transplantation evaluation. &ese prognostic markers in-
cluded PaO2 levels, FEV1, FEV1 % predicted, DLCO, DLCO
% predicted, FVC, and FVC % predicted. Biochemical pa-
rameters were obtained including blood haemoglobin level,
serum creatinine, serum albumin, serum bilirubin, presence
of anemia (male: haemoglobin <130 g/L; female: haemo-
globin <115 g/L), and presence of hypoalbuminemia (serum
albumin <35 g/L), and estimated glomerular filtration rate
(eGFR) was calculated using the modification of diet in renal
disease formula. Body mass index (BMI) was calculated as
weight/height [2] (kg/m2).
2.6. Outcome Measures Morbidity and Mortality.
Post-LTX intubation time, intensive care unit (ICU) length
of stay (LOS), hospital LOS, and 12-month post-LTX sur-
vival were recorded for all patients.
2.7. Assessment of Reversibility of Frailty. For patients
assessed as frail pre-LTX, follow-up frailty assessment,
cognition assessment, and depression screening were per-
formed following completion of the post-LTX rehabilitation
program.
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2.8. StatisticalAnalysis. Descriptive statistics were calculated
for all variables. &e number of patients within the nonfrail
and frail categories was determined for the study population.
Baseline characteristics are presented as mean± standard de-
viation or median and interquartile range for continuous
variables and frequency (percent) for categorical variables. &e
association between frailty category and age, sex, transplant
type, diagnostic category, cognition, depression, markers of
lung disease severity, and biochemical parameters was made
using independent-sample t-tests or Mann–Whitney U tests
for continuous variables and chi-square tests or where ap-
propriate Fisher’s exact test for categorical variables.
To compare outcomes, survival time was defined as the
time from the date of LTX and the date of death or date of
censoring (12 months post-LTX). Kaplan–Meier cumulative
survival curves were generated for each frailty category, and
the log-rank test was used to compare 12-month survival
rates between the frail and nonfrail groups. Post-LTX in-
tubation time was defined as “the time from intubation to
the time of extubation following LTX,” ICU LOSwas defined
as “the time from the date of transplant admission to ICU to
the date of discharge from ICU,” and hospital LOS was
defined as “the time from the date of transplant admission to
the date of discharge from hospital following LTX.” &e
association between frailty category and post-LTX intuba-
tion time, ICU LOS, and hospital LOS was made using
Mann–Whitney U tests.
To assess changes in physical frailty, individual frailty
domains including exhaustion, mobility, appetite, activity,
and HGS were compared at baseline and at follow-up. In
addition, depression and cognition were compared at
baseline and at follow-up. Related sample Wilcoxon signed-
rank test was used for continuous data and McNemar’s test
for categorical data. A p value of <0.05 was considered
statistically significant. All data analyses were conducted
using IBM SPSS, version 25 (IBM Corp., Armonk, NY).
3. Results
3.1. Frailty Prevalence. During the study period, 166 patients
(90M: 76F; age 54 (IQR 21) years, range 16–70) underwent
lung transplantation (159 bilateral LTX, 4 single LTX, and 3
heart-lung transplants). &e underlying causes of lung
disease were cystic fibrosis (23%), chronic obstructive pul-
monary disease including alpha-1 antitrypsin deficiency
(33%), interstitial lung disease (30%), pulmonary arterial
hypertension (3%), congenital heart disease (2%), chronic
lung allograft dysfunction (5%), and “others” (4%). &e
median time between pretransplant frailty assessment and
transplantation was 170 (IQR 220) days for frail patients and
167 (IQR 208) for nonfrail patients. Baseline demographics
are provided in Table 2. Twenty-seven patients were assessed
as frail (16%). Frailty was not associated with age, gender,
diagnosis, BMI, PaO2, FEV1 % predicted, and DLCO %
predicted. Frailty was associated with lower serum creati-
nine, haemoglobin and albumin, cognitive impairment (as a
categorical variable) and depression (as categorical and
continuous variables).
3.2. Frailty and Post-LTXOutcomes. At 12-month post-LTX
survival was 92% in the nonfrail group compared with 88%
in the frail group (p �NS, Mantel–Cox test) (Figure 1). Post-
LTX outcome for all 166 patients following reassessment of
frail patients is shown in Figure 2. Post-LTX intubation time,
ICU LOS, and hospital LOS outcomes by frailty status are
shown in Table 3. Postoperative ICU LOS was similar for the
nonfrail and frail groups.
We compared the baseline demographics for frail pa-
tients stratified by post-LTX mortality status and showed no
difference between frail patients that survived versus those
that died post-LTX. However, it is likely that our numbers
are too small to show any significance.
3.3.Reversibility ofFrail Pre-LTX. Of the 27 patients assessed
as frail pretransplantation, 8 died following LTX and before
reassessment, one interstate recipient failed to return for
reassessment, and 18 underwent post-LTX frailty reassess-
ment. Follow-up reassessments were conducted at the
median time of 357 (IQR 841) days post-LTX.
Amongst the patients assessed as frail pre-LTX, there was
no significant difference in the frailty scores of those who did
and did not survive (alive 3.37± 0.6; dead 3.63± 0.9, NS).
Amongst the surviving patients, there was a significant
improvement in frailty score post-LTX (from 3.4± 0.6 to
Table 1: Criteria for the modified Fried Frailty Phenotype (mFFP) binary score. A total of 5 physical domains were assigned 1 point if
present or 0 if absent with FFP scores ≥3 considered frail and FFP� 0–2 considered nonfrail.
Domain Scoring criteria
Exhaustion
“In the last week, did you feel on at least three days, that everything you did was an effort?” and “In the last
week, did you feel on at least three days, that you could not get going?” A response of “yes” to either question
met the criteria for exhaustion
Weakness (i.e., low grip
strength)
Grip strength was considered weak if the average of three consecutive attempts on the left and right hand fell
below two standard deviations of sex- and age-adjusted normative values
Mobility, i.e., slow gait speed Walking speed was considered slow if the average of three attempts took six seconds or more to complete5meters
Appetite “Have you, in the last three months, been eating more/less than usual?” A response of “less” was classified aspoor appetite
Physical activity
“How often do you engage in activities that require a low or moderate level of energy, such as gardening,
cleaning the car or going for a walk?” A response of “one to three times amonth or hardly ever” was classified
as physical inactivity
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1.0± 0.7, p< 0.001) (Figure 3). Of the 18 patients reassessed
post-LTX, 17 (94%) were recategorized as nonfrail, while
the remaining patient had an improvement in frailty score
(from 4 to 3; exhaustion, poor appetite, and reduced grip
strength) that did not meet the recategorization threshold.
3.4. Reversibility of Frailty Domains. Changes in the frailty
domains of 18 frail patients from pre-LTX to post-LTX are
shown in Figure 4.
Twelve (67%) patients met the criteria for exhaustion
pre-LTX. At reassessment, there was a significant
Table 2: Comparison of demographics and baseline prognostic markers of a study population stratified by physical frailty status.
Total (n� 166) Nonfrail (n� 139) Frail (n� 27) p value
Age (years) 54 (21) 54 (21) 54 (22) NS
Gender, male (%) 90 (54%) 79 (57%) 11 (41%) NS
Diagnosis
CF 39 (23%) 35 (25%) 4 (15%) NS
COPD/AAT 54 (33%) 48 (35%) 6 (22%)
ILD 50 (30%) 39 (28%) 11 (40%)
PAH 5 (3%) 4 (3%) 1 (4%)
CLAD 8 (5%) 4 (3%) 4 (15%)
CHD 4 (2%) 3 (2%) 1 (4%)
Others 6 (4%) 6 (4%) 0
Transplant type
Bilateral lung 159 (96%) 134 (96%) 25 (93%) NS
Single lung 4 (2.4%) 2 (1.4%) 2 (7%)
Heart-lung 3 (1.6%) 3 (2.6%) 0
Serum creatinine (μmol/L) 73± 21 75± 21 65± 19 0.02
eGFR (ml/min/m2) 82± 12 82± 12 84± 11 NS
Serum bilirubin (μmol/L) 10± 9 10± 10 6± 4 NS
Serum albumin (g/L) 43± 5 44± 5 40± 6 <0.001
Hypoalbuminaemia, n (%) 8 (5%) 4 (3%) 4 (15%) 0.03
Haemoglobin (g/L) 141± 19 143± 18 129± 22 0.001
Anemia, n (%) 18 (11%) 10 (7%) 8 (30%) 0.003
Abnormal MOCA, n (%) 42 (25%) 31 (22%) 11 (41%) 0.04
Abnormal DMI, n (%) 48 (29%) 33 (24%) 15 (56%) 0.001
PaO2 (mmHg) 64± 11 64± 10 64± 15 NS
FEV1 (% predicted) 39± 21 39± 21 39± 19 NS

























Figure 1: 12-month post-LTX survival in frail vs. nonfrail patients.
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improvement (p � 0.008) with 4 (22%) patients classified as
exhausted following LTX.
Twelve (67%) patients had slow walking speed pre-LTX.
&ere was a significant improvement (p< 0.001) with no (0%)
patients assessed as having slow walking speed post-LTX.
Fourteen (78%) patients were classified as having poor
appetite pre-LTX. At reassessment, there was significant
improvement (p< 0.001) with 2 (11%) patients reporting























Figure 2: Outcome of nonfrail vs. frail patients post-LTX following reassessment of frail patients.
Table 3: Comparison of clinical characteristics post-LTX of a study population stratified by physical frailty status.
Total (n� 166) Nonfrail (n� 139) Frail (n� 27) p value
Median (IQR)
Intubation post-LTX (hours) 24 (69) 23 (71) 31 (66) NS
ICU LOS (days) 5 (7) 5 (6) 4 (9) NS
Hospital LOS (days) 20 (21) 19 (19) 24 (30) NS

























































Figure 4: Changes to physical frailty domains pre-LTX vs. post-LTX.
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Twelve (67%) patients were classified as physically in-
active pre-LTX. &ere was significant improvement
(p< 0.001) with no (0%) patients classified as physically
inactive post-LTX.
Ten (56%) patients had reduced HGS pre-LTX. At
reassessment, there was no improvement (p �NS) in HGS.
In fact, HGS worsened, with 11 (61%) patients assessed as
having reduced HGS post-LTX.
3.5. Reversibility of Cognitive Impairment and Depression.
Changes in the DMI-10 of the 18 frail patients from pre-LTX
to post-LTX are shown in Figure 5. Of the 13 (72%) patients
classified as depressed pre-LTX, there was significant im-
provement in DMI-10 score (from 9.9± 6.9 to 5.4± 5.2,
p � 0.002) with 5 (28%) patients classified as depressed post-
LTX.
Changes in the MOCA of the 18 frail patients from pre-
LTX to post-LTX are shown in Figure 6. Of the 7 (39%)
patients classified as cognitively impaired pre-LTX, there
was significant improvement in MOCA score (from
26.5± 3.1 to 28.1± 2.1, p � 0.013) with 2 (11%) patients
classified as cognitively impaired post-LTX. Although still
classified as cognitively impaired, the 2 patients saw im-
provements in their MOCA score post-LTX (23 to 25 and 19
to 21).
4. Discussion
&emajor finding of our study is that in those who survived,
physical frailty was largely reversible following lung trans-
plantation. Of the 18 frail patients, significant improvements
were seen in 17 (94%) patients (p � 0.001). We believe this
study to be one of the first to investigate the reversibility of
the individual physical frailty domains following LTX.
Frailty has previously been shown to improve within the
first 6months following LTX [17]. Significant improvements
were seen in the following physical frailty domains: ex-
haustion (p � 0.008), mobility, appetite, and activity (all
p< 0.001). Walk speed as assessed by six-minute walk
distance and time spent in moderate-intensity physical
exercise has previously been reported to significantly im-
prove from hospital discharge to 3 months post-LTX [22].
Interestingly, exhaustion was reported to be prevalent in
56% of lung transplant recipients at routine follow-up
(1–5 years post-LTX), with psychological distress the most
significant predictor of exhaustion [23].&is may be due to a
number of factors including post-TX mood change, cog-
nitive problems, and unrealistic expectations of the TX
process. A better understanding of the trajectory of the
individual frailty domains following LTX may help clini-
cians determine the most appropriate prehabilitation
interventions.
Reduced HGS has been suggested as a single-item
surrogate measure of frailty [24] and it is therefore of interest
that this was one domain where reversibility was not
demonstrated post-LTX. However, these results are con-
sistent with those we have reported in the heart transplant
population [25]. In a group of 23 lung transplant recipients,
Candemir and colleagues reported HGS remained lower
than in healthy individuals following an 8-week outpatient


































































Figure 6: Changes in MOCA score pre-post LTX.
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Conversely, in heart failure patients undergoing ven-
tricular assist device (VAD) placement, HGS significantly
increased post-VAD implantation compared with baseline
[24]. Corticosteroid-induced myopathy is well documented
[27] with inverse correlations found between skeletal muscle
strength and the amount of corticosteroids ingested [28].
&is suggests that post-TX steroid ingestion may contribute
to reduced muscle strength affecting HGS and that a
comprehensive frailty tool, such as the FFP, may be more
sensitive to detecting changes in frailty status over a single-
item measure, such as HGS. Further research is necessary to
determine the most appropriate frailty measure in lung
transplantation, to determine the factors that contribute to
weak HGS following the procedure and develop appropriate
pre-LTX interventions.
&e reversibility of frailty was first proposed by Flint and
colleagues [29]. It was hypothesized that the relative pro-
portion of disease-specific and non-disease-specific factors
comprising a patient’s frailty status was indicative of the
potential for change, with disease-specific factors more likely
to reverse following intervention.
&is would suggest that, in certain patients with ad-
vanced lung disease, a number of presumably disease-spe-
cific frailty domains including walk speed, exhaustion, and
physical activity would be amenable to interventions such as
transplantation.
Further research is necessary in the population of frail
patients with advanced lung disease to identify character-
istics that are associated with an increased risk of mortality
either before or after lung transplantation, thereby im-
proving risk stratification and ensuring those selected for
lung transplantation sustain a significant survival benefit [1].
Our center does not have an upper age limit for
transplantation and considers frailty in conjunction with
comorbidities when evaluating a patient’s suitability for
transplant. While we do not consider age an absolute
contraindication to LTX, increasing age is generally asso-
ciated with other relative contraindications, such as
comorbidities, that place older LTX candidates at increased
risk of morbidity and mortality following LTX [2]. While we
expected that older patients would demonstrate higher rates
of frailty and less reversibility of frailty than their younger
counterparts, we did not find any association between age
and frailty within the population of patients referred for LTX
evaluation. Furthermore, in those patients that survived, we
found frailty to be reversible across age groups, challenging
the concern that frailty would be less reversible in older LTX
recipients.
Several authors have reported recently that pre-LTX
frailty is associated with increased morbidity and mortality
before and after LTX [6–8,30]. Although not statistically
significant, frail patients in our study demonstrated a trend
towards increased hospital LOS following LTX. In light of
these reports, it is clearly important to carefully consider the
frailty status of all patients referred for lung transplantation
[3]; however, the largely reversible nature of the frailty
phenotype as demonstrated in this study and recently by
others [8,17,30] supports the idea that frailty should not be
considered a contraindication to transplantation.
Frailty has been associated with a decline in cognitive
function, with research increasingly considering cognition
in the definition of frailty [31, 32]. We have previously
reported that the addition of cognitive impairment to the
assessment of physical frailty increased the capacity to
identify early mortality in those undergoing evaluation for
heart transplant [9]. A recent report on frailty in solid organ
transplantation recognized additional factors may contrib-
ute to frailty in transplant candidates and suggested the
MOCA be used to assess cognition in the evaluation of frailty
in lung transplant candidates [3]. Using the MOCA to assess
cognitive function pre- and post-LTX, we saw significant
improvements in cognitive function following transplan-
tation (MOCA score from 26.5± 3.1 to 28.1± 2.1, p � 0.013).
In another study, the MOCA was used to assess cognitive
impairment in a cohort of 47 LTX with 21 (45%) exhibiting
neurocognitive impairment pretransplantation [33]. After
transplantation, 27 (57%) recipients exhibited impairment
in the early postoperative period and 19 (40%) participants
continued to exhibit impairment at a 3-month follow-up.
Comparable results were reported in a study of 49 lung
transplant recipients, which demonstrated that one-third of
patients experienced significant cognitive impairment from
baseline to posttransplant [34]. However, a subset of older,
less educated patients demonstrated significant cognitive
decline from pretransplant to 6months posttransplant [34].
In addition, among individuals with a diagnosis other than
cystic fibrosis who experienced postoperative delirium,
cognitive function was poorer than among nondelirious
patients at 3 months following lung transplantation [33].
Among patients with cystic fibrosis, cognitive improvements
were seen 3 months posttransplant and attributed to im-
provements in hypoxia and nonspecific factors such as fa-
tigue [33].
Depression has been related to hippocampal atrophy and
subsequent mild cognitive impairment as well as the de-
velopment or worsening of the physical frailty syndrome
[32]. &e DMI-10 tool has been established as a valid
screening tool that was designed to avoid symptoms (e.g.,
poor concentration and loss of appetite) common to medical
illness [21]. Our study demonstrated a significant association
between frailty and depression pretransplant (p � 0.001).
Significant improvements (p � 0.001) were seen in de-
pression post-LTX, with 8 out of 13 patients reclassified as
“not depressed”. In their meta-analysis, Soysal et al. [35]
concluded that there was a bidirectional relationship be-
tween depression and frailty, and one may be a risk factor for
the development of the other. Cognitive impairment and
depression are common amongst lung transplant candidates
and may persist or worsen following LTX [33,36]. A number
of frailty measures now incorporate psychosocial domains of
frailty [10].
Further research is needed to provide insight into how
current frailty measures may be modified to better capture
frailty and predict outcomes in lung transplant candidates
and recipients. Given the prevalence of cognitive impair-
ment and depression in lung transplant candidates, a more
comprehensive frailty measure may be required to provide
clear indicators of which lung transplant recipients are no
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longer “frail” following transplant. &e trajectory of frailty,
cognitive function, and depression before and after lung
transplantation is largely unknown [34]. Further research is
needed to examine the interaction between frailty, cognitive
impairment, and depression in lung transplantation and
determine the most appropriate frailty measure in this
population.
Our findings contribute to the evidence demonstrating
that frailty associated with advanced disease is largely re-
versible following transplantation. A single-center study of
246 LTX recipients demonstrated that frailty measured by
short physical performance battery (SPPB) and FFP im-
proved early after transplant and subsequently remained
stable [17]. Following bridge to transplantation VAD im-
plantation, or heart transplantation, 24 out of 26 patients
showed significant improvements in their frailty scores [25].
In a cohort of 349 kidney transplant recipients, frailty
worsened at 1month post-TX before significantly improving
at 3 months [37].
Similarly, in a group of 214 liver transplant recipients,
their frailty scores worsened at 3 months post-TX and
improved modestly by 12 months [38]. &is would suggest it
is premature to delist a patient based purely on their frailty
status alone and emphasizes the importance of considering
frailty in combination with other comorbidities. Moreover,
this underscores the need to identify and implement specific
interventions to improve frailty.
Research has begun to focus on interventions to mod-
erate the risks of frailty [16,39,40]. Frailty was reported to be
reversible in a group of chronic obstructive pulmonary
disease patients following pulmonary rehabilitation com-
pletion [40]. Studies examining exercise training before and
after lung transplantation reported significant improve-
ments in exercise capacity, muscle strength, and physical
frailty score [16,41]. &ese findings support the theory that
frailty is largely responsive to intervention [42] and provide
strong evidence to further explore the optimal management
of frail patients through appropriate interventions. Further
research on pulmonary rehabilitation, nutritional supple-
mentation, and psychosocial involvement may help establish
appropriate interventions to address frailty before and after
LTX [3].
5. Limitations
Our study has several limitations. Firstly, the study is from a
single center with a small number of patients.
Secondly, our study aims to determine whether frailty
identified pre-LTX is reversible posttransplant and does not
assess those classified as nonfrail pre-LTX. As our program is
fully funded by the Australian public healthcare system, we
have a finite number of resources and our patients reside
across a large geographical area. As such, we focused on the
frail group rather than the total transplant population.
&irdly, there was a variable duration between baseline
frailty assessment and LTX, but this is inevitable given that
the time of transplantation cannot be predicted.
However, all patients are reviewed every 3 months by the
LTX physicians at our center and any concern regarding
deterioration in an individual patient leads to reassessment
of their frailty and suitability for transplantation in con-
junction with other comorbidities. During the study period,
none of the patients required reassessment for LTX
suitability.
Fourthly, while all patients were reassessed following
completion of the mandatory post-LTX rehabilitation
program following discharge, there was considerable vari-
ation in the timing of this post-LTX frailty assessment.
Despite this limitation, the timing of the post-LTX frailty
assessment did not affect the critical findings of post-LTX
reversibility.
Furthermore, there is survivor bias, as frail patients must
survive to transplant and frailty reassessment. Nonetheless,
it is noteworthy that the posttransplant survival of frail
patients was 88% at one year and not significantly inferior to
that of nonfrail lung transplant recipients. Moreover, the
posttransplant survival of both frail and nonfrail patients in
our program compares favourably to the posttransplant
survival of lung transplant recipients reported by the Reg-
istry of the International Society for Heart and Lung
Transplantation [2].
A further limitation to our study is the use of a modified
frailty tool. Our unit evaluates patients for both heart and
lung transplants. &is tool is used in all patients referred to
our unit: it is simple to administer and clinically feasible for
our population. However, it has been validated in the ad-
vanced heart failure population [19] but not yet been vali-
dated in the LTX population.
6. Conclusions
In those assessed as frail during LTX evaluation, frailty was
largely reversible following LTX in those patients who
survived to reassessment. Improvements were seen in the
physical frailty domains of exhaustion, walking speed, ap-
petite, and physical activity. &ere was no improvement in
grip strength. &is underscores the importance of consid-
ering frailty as a dynamic, not a fixed, entity. In addition,
there was also an improvement in depression and cognition
scores in a number of patients following LTX, but a small
subset showed a cognitive decline.
Patients referred for transplantation may greatly benefit
from early intervention. Prehabilitation with an emphasis on
intervention before surgery may impact function and op-
timize postoperative recovery [43]. Further work is needed
to identify those patients whose frailty is modifiable and
establish specific interventions to target frailty.
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